91 related articles for article (PubMed ID: 8018849)
1. Anticonvulsant activities of N-benzyloxycarbonylglycine after parenteral administration.
Lambert DM; Poupaert JH; Maloteaux JM; Dumont P
Neuroreport; 1994 Mar; 5(7):777-80. PubMed ID: 8018849
[TBL] [Abstract][Full Text] [Related]
2. N-(benzyloxycarbonyl)glycine esters and amides as new anticonvulsants.
Geurts M; Poupaert JH; Scriba GK; Lambert DM
J Med Chem; 1998 Jan; 41(1):24-30. PubMed ID: 9438018
[TBL] [Abstract][Full Text] [Related]
3. Anticonvulsant drug potentiation by glycine in maximal electroshock seizures is mimicked by D-serine and antagonized by 7-chlorokynurenic acid.
Peterson SL
Eur J Pharmacol; 1991 Jul; 199(3):341-8. PubMed ID: 1655484
[TBL] [Abstract][Full Text] [Related]
4. Potentiation by glycine of anticonvulsant drugs in maximal electroshock seizures in rats.
Peterson SL; Trzeciakowski JP; Frye GD; Adams HR
Neuropharmacology; 1990 Apr; 29(4):399-409. PubMed ID: 2342638
[TBL] [Abstract][Full Text] [Related]
5. Classification of compounds for prevention of NMDLA-induced seizures/mortality, or maximal electroshock and pentylenetetrazol seizures in mice and antagonism of MK801 binding in vitro.
Palmer GC; Harris EW; Ray R; Stagnitto ML; Schmiesing RJ
Arch Int Pharmacodyn Ther; 1992; 317():16-34. PubMed ID: 1456842
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic analysis and anticonvulsant activity of glycine and glycinamide derivatives.
Sussan S; Dagan A; Bialer M
Epilepsy Res; 1999 Jan; 33(1):11-21. PubMed ID: 10022362
[TBL] [Abstract][Full Text] [Related]
7. Glycine derivatives of imidazolones as potential ligands of glycine binding site of NMDA receptors. Part 1.
Kieć-Kononowicz K; Karolak-Wojciechowska J; Handzlik J
Acta Pol Pharm; 1998; 55(5):381-8. PubMed ID: 9921116
[TBL] [Abstract][Full Text] [Related]
8. Selective antagonism of the anticonvulsant effects of felbamate by glycine.
Coffin V; Cohen-Williams M; Barnett A
Eur J Pharmacol; 1994 Apr; 256(2):R9-10. PubMed ID: 8050461
[TBL] [Abstract][Full Text] [Related]
9. Glycine transporter 1 (GlyT1) inhibitors exhibit anticonvulsant properties in the rat maximal electroshock threshold (MEST) test.
Kalinichev M; Starr KR; Teague S; Bradford AM; Porter RA; Herdon HJ
Brain Res; 2010 May; 1331():105-13. PubMed ID: 20303337
[TBL] [Abstract][Full Text] [Related]
10. MDL 27,531 selectively reverses strychnine-induced seizures in mice.
Kehne JH; Kane JM; Miller FP; Ketteler HJ; Braun DL; Senyah Y; Chaney SF; Abdallah A; Dudley MW; Ogden AM
Br J Pharmacol; 1992 Aug; 106(4):910-6. PubMed ID: 1327393
[TBL] [Abstract][Full Text] [Related]
11. Anticonvulsant effects of some inhibitory neurotransmitter amino acids.
Toth E; Lajtha A; Sarhan S; Seiler N
Neurochem Res; 1983 Mar; 8(3):291-302. PubMed ID: 6134243
[TBL] [Abstract][Full Text] [Related]
12. [Simple derivatives of amino acid neurotransmitters. Anticonvulsant evaluation of derived amides, carbamates and esters of glycine and beta-alanine].
Lambert DM; Geurts M; Scriba GK; Poupaert JH; Dumont P
J Pharm Belg; 1995; 50(2-3):194-203. PubMed ID: 7674119
[TBL] [Abstract][Full Text] [Related]
13. Glycine potentiation of anticonvulsant drugs in pentylenetetrazol seizures in rats.
Peterson SL
Brain Res Bull; 1991 Jan; 26(1):43-7. PubMed ID: 2015517
[TBL] [Abstract][Full Text] [Related]
14. Anticonvulsant activity of milacemide.
van Dorsser W; Barris D; Cordi A; Roba J
Arch Int Pharmacodyn Ther; 1983 Dec; 266(2):239-49. PubMed ID: 6667068
[TBL] [Abstract][Full Text] [Related]
15. Influence of N-hydroxymethyl-p-isopropoxyphenylsuccinimide on the anticonvulsant action of different classical antiepileptic drugs in the mouse maximal electroshock-induced seizure model.
Luszczki JJ; Kominek M; Florek-Luszczki M; Tchaytchian DA; Kocharov SL; Zolkowska D
Epilepsy Res; 2012 Jun; 100(1-2):27-36. PubMed ID: 22281062
[TBL] [Abstract][Full Text] [Related]
16. Structure and activity studies on glycine receptor ligands. Part 5. Diphenyl imidazolin-4-one glycinamides.
Kieć-Kononowicz K; Karolak-Wojciechowska J
Acta Pol Pharm; 1998; 55(5):389-96. PubMed ID: 9921117
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of glycine on the anticonvulsant activity of D-cycloserine and L-701,324 in mice.
Wlaź P; Poleszak E
Pharmacol Rep; 2011; 63(5):1231-4. PubMed ID: 22180366
[TBL] [Abstract][Full Text] [Related]
18. Effect of the glycine/NMDA receptor partial agonist, D-cycloserine, on seizure threshold and some pharmacodynamic effects of MK-801 in mice.
Wlaź P; Baran H; Löscher W
Eur J Pharmacol; 1994 May; 257(3):217-25. PubMed ID: 8088343
[TBL] [Abstract][Full Text] [Related]
19. Evidence for anticonvulsant and neuroprotectant action of felbamate mediated by strychnine-insensitive glycine receptors.
McCabe RT; Wasterlain CG; Kucharczyk N; Sofia RD; Vogel JR
J Pharmacol Exp Ther; 1993 Mar; 264(3):1248-52. PubMed ID: 8383742
[TBL] [Abstract][Full Text] [Related]
20. Anticonvulsant activity of antagonists for the NMDA-associated glycine binding site.
Nichols AC; Yielding KL
Mol Chem Neuropathol; 1993 Aug; 19(3):269-82. PubMed ID: 8397587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
